- Peligros potenciales que acechan a la Tierra desde el espacio exterioron 29/04/2024
La Tierra se encuentra constantemente expuesta a una variedad de amenazas cósmicas que pueden tener un impacto devastador en nuestro planeta y en la vida que lo habita. Desde asteroides y cometas hasta eventos de radiación solar y supernovas distantes, estas amenazas representan desaf& …
- How AI can be a catalyst for building a change-ready cultureon 29/04/2024
Top healthcare organizations use three proven strategies to strengthen culture while integrating AI.
- Empowering healthcare providers against rising payer denialson 29/04/2024
The rise in denial rates is more than a mere statistic; it’s a symptom of a broader systemic challenge that calls for strategic foresight and robust expertise.
- Lago de lava de Ío, naves de carga lunares, muestra que podría conservar huellas de vida marcianaon 29/04/2024
Noticias de la actualidad astronómica y astronáutica del 29 de abril de 2024. …
- La ciencia de la estratigrafíaon 29/04/2024
En las capas de roca que componen la corteza terrestre yacen los registros silenciosos de la historia de nuestro planeta. La estratigrafía, una disciplina científica dedicada al estudio de estas capas geológicas, nos ofrece una ventana única para comprender el pasado de l …
- Las emisiones térmicas de los planetas y su importancia cósmicaon 29/04/2024
Más allá de la luz visible que alcanza nuestros ojos, se encuentra un mundo invisible pero fascinante: las emisiones térmicas de los planetas. Estas emisiones, que son radiaciones infrarrojas liberadas por los cuerpos celestes, ofrecen una ventana única para comprender la …
- Los grupos de galaxias más próximos al Grupo Localon 29/04/2024
El Grupo Local, que abarca unas 54 galaxias conocidas, es una colección diversa de sistemas estelares que incluye la Vía Láctea, Andrómeda y otras galaxias más pequeñas. Se encuentra a una distancia aproximada de 10 millones de años luz de la Tierra y …
- Implicaciones éticas de la Inteligencia Artificial en la seguridad nacionalon 29/04/2024
En la era de la inteligencia artificial (IA), la intersección entre la seguridad nacional y la ética ha adquirido una importancia sin precedentes. A medida que los avances en IA transforman las capacidades militares y de seguridad, surge la necesidad de abordar cuidadosamente las impli …
- Destinos Top para Rinoplastia: Descubre lo Mejor en Cirugía Estéticaon 29/04/2024
¿Buscas mejorar tu apariencia nasal? Explora los destinos destacados para cirugía de nariz. Descubre cuánto cuesta una rinoplastia en Turquía, México, Lituania, República Dominicana y Corea del Sur. Prepárate para conocer lo mejor en cirugía es …
- Paul Nipkow: Pionero de la televisión y la tecnología de escaneoon 29/04/2024
Conocido por sus contribuciones revolucionarias al campo de la televisión y la tecnología de escaneo, la vida y el legado de Paul Nipkow continúan inspirando a generaciones de innovadores en todo el mundo. El Pionero Desconocido: Aunque su nombre puede no ser tan recono …
- Combatir el alcoholismo: Estrategias efectivas respaldadas por la cienciaon 29/04/2024
El alcoholismo es un problema de salud pública que afecta a millones de personas en todo el mundo. Las consecuencias devastadoras del abuso del alcohol no solo impactan la salud física y mental de los individuos, sino también sus relaciones interpersonales, su desempeño l …
- Immunovia Publishes Interim Report for January-March 2024on 29/04/2024
On April 9, the Company announced that Immunovia had successfully developed accurate and precise assays to measure targeted proteins for its next-generation test.
- 4P-Pharma Announces Total Capital of €15 Million Successfully Secured in Second Closingon 29/04/2024
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of €15 million in its second closing with participation from private investors.
- AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)on 29/04/2024
AriBio Co., Ltd. announced authorisation from the European Medicines Agency for POLARIS-AD, a global, phase 3, early Alzheimer’s disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency on the Clinical Trial Authorisation of POLARIS-AD.
- Spectrum Dynamics Medical and Hermes Medical Solutions Enter Into Partnership to Offer Integrated Solution of the Hermia Software With the VERITON-CT Scanneron 29/04/2024
Spectrum Dynamic’s customers will benefit from Hermia’s best-in-class nuclear medicine and dosimetry software applications to fully leverage the unique technology and image quality of VERITON-CT scans.
- ENHERTU® Demonstrated Statistically Significant & Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trialon 29/04/2024
Positive topline results from the DESTINY-Breast06 phase 3 trial showed that ENHERTU® demonstrated a statistically significant and clinically meaningful improvement in progression-free survival compared to standard of care chemotherapy in the primary trial population of patients with HR positive, HER2 low metastatic breast cancer following one or more lines of endocrine therapy.
- What’s Next for Obesity Therapeutics? Higher Quality Weight Losson 29/04/2024
With GLP-1 agonists slated to become the best-selling drugs in 2024, the biopharma industry is already pivoting to explore treatments that preserve muscle mass as patients shed pounds.
- 5 Mid-Stage ALS Drugs to Watchon 29/04/2024
As the Phase III amyotrophic lateral sclerosis pipeline thins out, the ALS community is placing its hopes on earlier-stage trials sponsored by Denali Therapeutics, PTC Therapeutics and more.
- Opinion: Larimar Could Compete with Biogen in Friedreich’s Ataxiaon 29/04/2024
Phase II data indicate Larimar Therapeutics’ injectable therapy nomlabofusp could go head-to-head in the market with Biogen’s Skyclarys.
- Evox Therapeutics Names Co-Founder Dr. Per Lundin as Chief Executive Officeron 29/04/2024
Evox Therapeutics Ltd, a leading exosome therapeutics company, announces that Dr. Per Lundin, Co-Founder and Chief Business Officer, has been appointed as Chief Executive Officer of the Company and will be appointed to its Board of Directors.
- As Autism Cases Rise, Biopharma Springs Into Actionon 29/04/2024
Several companies—including Roche, Curemark and Yamo Pharmaceuticals—are running clinical trials of treatments that aim to offset the myriad challenges of autism.
- OBiO Technology will showcase at American Society of Gene & Cell Therapyon 28/04/2024
OBiO Technology Corp., Ltd. will showcase at American Society of Gene & Cell Therapy in Maryland, USA from May 7th to 11th.
- ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biologyon 27/04/2024
ReNAgade Therapeutics announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem.
- Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024on 27/04/2024
Longhorn Vaccines and Diagnostics presented positive data from three key studies of its infectious disease franchise at the European Congress of Clinical Microbiology and Infectious Diseases 2024.